Type 2 diabetics 'let down' over delayed treatment

April 26, 2016

People with Type 2 diabetes are being 'let down' because they are being forced to wait for further treatment when needed.

Research has shown the average waiting time for increased from the start of insulin is 3.7 years.

Maintaining tight control of blood sugars in people with Type 2 can lead to significant reductions in related complications, previous evidence has shown.

However 'clinical inertia', which is the term given for the delay of increasing medication needed for patients, is preventing this from happening, according to a study published in the Diabetes, Obesity and Metabolism journal.

The research was carried out by NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, an organisation which turns research into cost-saving and high-quality care through cutting-edge innovation.

Professor Kamlesh Khunti, Director of CLAHRC East Midlands and Professor of Primary Care Diabetes & Vascular Medicine at the University of Leicester based at the Leicester Diabetes Centre, said: "Of the 11,000 patients we studied, only a third of those needing further medication were actually given it.

"Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.

"Failure by healthcare professionals to intensify medication in the pursuit of tighter glycaemic control is due to a number of complex reasons related to patient and health care professional factors. However, we need to make great efforts to reverse these trends and improve patients reaching tight glucose targets from diagnosis of diabetes"

The study concluded that more should be done to avoid clinical inertia and should have their treatment intensified where appropriate.

Long-term complications and mortality associated with Type 2 diabetes can be significantly reduced if therapies are initiated earlier.

Explore further: Drive to reduce 999 diabetes calls in East Midlands starts

More information: K. Khunti et al. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin, Diabetes, Obesity and Metabolism (2016). DOI: 10.1111/dom.12626

Related Stories

Type 2 diabetes screening needs 'reviewing'

October 13, 2015

The process for screening for Type 2 diabetes or those at high risk of the condition needs "careful re-evaluation", according to the first study on the effectiveness of testing methods.

Chronic conditions rise in older people

February 29, 2016

The number of older people in England living with more than one chronic condition could have risen by ten per cent in the last decade putting increasing pressure on the NHS, new research has suggested.

Recommended for you

Many diabetes patients produce some insulin

June 22, 2017

Some insulin is still produced in almost half of patients that have had type 1 diabetes for more than ten years. The study conducted by researchers at Uppsala University in Sweden has now been published online by the medical ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.